Urogen Pharma Ltd. · NASDAQ:URGN
Schoenberg Mark sold 10,000 Urogen Pharma Ltd. shares (Form 4)
Traded May 8, 2026 · Filed May 11, 2026
On May 8, 2026, Schoenberg Mark (Chief Medical Officer) sold 10,000 Urogen Pharma Ltd. shares at US$30.00 for US$300K under a trading plan, leaving 134,985 shares. Filed May 11, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$30.00
- Value
- US$300K
- Holding after
- 134,985 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Ordinary Shares | Sale | 10,000 | US$30.00 | 134,985 | Direct |
Source
Related
- Urogen Pharma Ltd.
- Schoenberg Mark
- Urogen Pharma Ltd. shareholders
- Form 4 · Schoenberg Mark · Sep 9, 2026
- Form 4 · Schoenberg Mark · Aug 24, 2026
- Form 4 · Schoenberg Mark · Jul 10, 2026
- Form 4 · Schoenberg Mark · Jun 24, 2026
- Form 4 · Schoenberg Mark · Jun 9, 2026
- Form 4 · Degnan Chris · Oct 9, 2026
- Form 4 · Smith Jason Drew · Sep 9, 2026
- Form 4 · Robinson James A. Jr. · Aug 28, 2026
- Form 4 · Robinson James A. Jr. · May 27, 2026